Endoscopy Devices are medical devices used to examine internal organs for diagnosis and treatment of diseases. A Resectoscope is a surgical instrument primarily used for resection and removal of tissue from the uterus, prostate, bladder, or urethra. GlobalData uses proprietary data and analytics to provide a comprehensive report on the resectoscopes devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the resectoscopes market in the US was KARL STORZ SE followed by Olympus, Richard Wolf and Stryker.
A Resectoscope is a type of endoscope, an instrument that combines a camera to allow for viewing of the surgical site during surgery and instrumentation. Resectoscopes typically have electrocautery and coagulation capabilities. Rigid Resectoscopes is a solid, straight resectoscope with a wide-angle telescope, tubular outer and inner sheaths, working element, and an obturator.
The value of the resectoscopes devices market within the US was expected to be over $30m in 2023.
For the latest complete market share analysis of resectoscopes device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
